Search

everythinglearnresearchcommunity

for

Search:↓

The decision board effectively helps lupus nephritis patients in Brazil choose treatments by clearly presenting options and side effects.

The ID2 gene can help distinguish between sensitizers and irritants in skin cells.

QMSI is a valuable method for studying drug penetration in skin tissues.

Research on non-muscle invasive bladder cancer has increased, with the U.S. leading, and highlights effective treatments like BCG despite some side effects.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

Controlled microflora in animals delays immune cell maturation and affects immunity.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

The study found that sweat glands normally suppress immune responses, but this is disrupted in certain skin diseases, possibly contributing to their development.

Parental uveitis increases offspring's risk and severity of autoimmune eye disease.

Inflammation damages sweat ducts, causing sweat gland injury.

Choosing the right tools is crucial for accurately measuring lupus activity and damage.

Targeted immunological therapies offer safer and more effective treatments for skin conditions like eczema and psoriasis.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Dermatologists vary widely in testing practices for alopecia areata, often exceeding guideline recommendations.

Clonally expanded CD8+ T cells cause alopecia areata.

Pediatric alopecia areata is more immune-active than adult cases, suggesting age-specific treatments and potential use of JAK inhibitors.

Dermal IgA deposition without symptoms is rare in Dermatitis herpetiformis risk groups.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Higher IL-21 levels may help predict alopecia areata activity.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Mast cell and nerve fiber interactions in mouse skin change with the hair cycle.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Personalized treatment considering atopic status and cytokine profiles may help in managing pediatric alopecia areata.

The 2012 criteria are better for diagnosing atypical lupus cases.